Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 30

1.

Public health impact of including two lineages of influenza B in a quadrivalent seasonal influenza vaccine.

Reed C, Meltzer MI, Finelli L, Fiore A.

Vaccine. 2012 Mar 2;30(11):1993-8. doi: 10.1016/j.vaccine.2011.12.098. Epub 2012 Jan 5.

PMID:
22226861
2.

Influenza vaccination of schoolchildren and influenza outbreaks in a school.

Kawai S, Nanri S, Ban E, Inokuchi M, Tanaka T, Tokumura M, Kimura K, Sugaya N.

Clin Infect Dis. 2011 Jul 15;53(2):130-6. doi: 10.1093/cid/cir336.

PMID:
21690619
3.

Comparison of clinical features and outcomes of medically attended influenza A and influenza B in a defined population over four seasons: 2004-2005 through 2007-2008.

Irving SA, Patel DC, Kieke BA, Donahue JG, Vandermause MF, Shay DK, Belongia EA.

Influenza Other Respir Viruses. 2012 Jan;6(1):37-43. doi: 10.1111/j.1750-2659.2011.00263.x. Epub 2011 May 25.

4.

Clinical manifestations and socio-economic impact of influenza among healthy children in the community.

Esposito S, Cantarutti L, Molteni CG, Daleno C, Scala A, Tagliabue C, Pelucchi C, Giaquinto C, Principi N.

J Infect. 2011 May;62(5):379-87. doi: 10.1016/j.jinf.2011.02.015. Epub 2011 Mar 15.

PMID:
21414357
5.

Prevalence of antibodies against seasonal influenza A and B viruses in children in Netherlands.

Bodewes R, de Mutsert G, van der Klis FR, Ventresca M, Wilks S, Smith DJ, Koopmans M, Fouchier RA, Osterhaus AD, Rimmelzwaan GF.

Clin Vaccine Immunol. 2011 Mar;18(3):469-76. doi: 10.1128/CVI.00396-10. Epub 2011 Jan 5.

6.

Clinical efficacy of cell culture–derived and egg‐derived inactivated subunit influenza vaccines in healthy adults.

Frey S, Vesikari T, Szymczakiewicz-Multanowska A, Lattanzi M, Izu A, Groth N, Holmes S.

Clin Infect Dis. 2010 Nov 1;51(9):997-1004. doi: 10.1086/656578.

PMID:
20868284
7.

Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010.

Fiore AE, Uyeki TM, Broder K, Finelli L, Euler GL, Singleton JA, Iskander JK, Wortley PM, Shay DK, Bresee JS, Cox NJ; Centers for Disease Control and Prevention (CDC).

MMWR Recomm Rep. 2010 Aug 6;59(RR-8):1-62. Erratum in: MMWR Recomm Rep. 2010 Aug 13;59(31):993. MMWR Recomm Rep. 2010 Sep 10;59(35):1147.

8.

Effects of oseltamivir treatment on duration of clinical illness and viral shedding and household transmission of influenza virus.

Ng S, Cowling BJ, Fang VJ, Chan KH, Ip DK, Cheng CK, Uyeki TM, Houck PM, Malik Peiris JS, Leung GM.

Clin Infect Dis. 2010 Mar 1;50(5):707-14. doi: 10.1086/650458.

9.

High proportion of influenza B characterises the 2008 influenza season in Victoria.

Grant KA, Carville K, Fielding JE, Barr IG, Riddell MA, Tran T, Kelly HA.

Commun Dis Intell Q Rep. 2009 Sep;33(3):328-36.

10.

Efficacy of live attenuated influenza vaccine in children against influenza B viruses by lineage and antigenic similarity.

Belshe RB, Coelingh K, Ambrose CS, Woo JC, Wu X.

Vaccine. 2010 Feb 25;28(9):2149-56. doi: 10.1016/j.vaccine.2009.11.068. Epub 2009 Dec 8.

PMID:
20003926
11.

Vaccine production capacity for seasonal and pandemic (H1N1) 2009 influenza.

Collin N, de Radiguès X; World Health Organization H1N1 Vaccine Task Force.

Vaccine. 2009 Aug 20;27(38):5184-6. doi: 10.1016/j.vaccine.2009.06.034. Epub 2009 Jun 27.

PMID:
19563891
12.

Challenge of conducting a placebo-controlled randomized efficacy study for influenza vaccine in a season with low attack rate and a mismatched vaccine B strain: a concrete example.

Beran J, Wertzova V, Honegr K, Kaliskova E, Havlickova M, Havlik J, Jirincova H, Van Belle P, Jain V, Innis B, Devaster JM.

BMC Infect Dis. 2009 Jan 17;9:2. doi: 10.1186/1471-2334-9-2.

13.

Long time trends in influenza-like illness and associated determinants in The Netherlands.

Dijkstra F, Donker GA, Wilbrink B, Van Gageldonk-Lafeber AB, Van Der Sande MA.

Epidemiol Infect. 2009 Apr;137(4):473-9. doi: 10.1017/S095026880800126X. Epub 2008 Sep 15.

PMID:
18789176
14.

Decreased leukocytes and other characteristics of laboratory findings of influenza virus infections in children.

Shen CF, Huang SC, Wang SM, Wang JR, Liu CC.

J Microbiol Immunol Infect. 2008 Aug;41(4):294-300.

PMID:
18787735
15.

Duration of protection provided by live attenuated influenza vaccine in children.

Ambrose CS, Yi T, Walker RE, Connor EM.

Pediatr Infect Dis J. 2008 Aug;27(8):744-8. doi: 10.1097/INF.0b013e318174e0f8.

PMID:
18600188
16.

Clinical features of children infected with different strains of influenza B in southern Taiwan.

Chi CY, Wang SM, Lin CC, Wang HC, Wang JR, Su IJ, Liu CC.

Pediatr Infect Dis J. 2008 Jul;27(7):640-5. doi: 10.1097/INF.0b013e31816be008.

PMID:
18520968
17.

The evolutionary dynamics of human influenza B virus.

Chen R, Holmes EC.

J Mol Evol. 2008 Jun;66(6):655-63. doi: 10.1007/s00239-008-9119-z. Epub 2008 May 27.

18.

Monitoring the impact of influenza by age: emergency department fever and respiratory complaint surveillance in New York City.

Olson DR, Heffernan RT, Paladini M, Konty K, Weiss D, Mostashari F.

PLoS Med. 2007 Aug;4(8):e247.

19.

A global pandemic influenza vaccine action plan.

Kieny MP, Costa A, Hombach J, Carrasco P, Pervikov Y, Salisbury D, Greco M, Gust I, LaForce M, Franco-Paredes C, Santos JI, D'Hondt E, Rimmelzwaan G, Karron R, Fukuda K.

Vaccine. 2006 Sep 29;24(40-41):6367-70.

PMID:
17240560
20.

Impact of influenza treatment with oseltamivir on health, sleep and daily activities of otherwise healthy adults and adolescents.

Bettis R, Iacuzio D, Jung T, Fuchs R, Aultman R, Gyldmark M.

Clin Drug Investig. 2006;26(6):329-40.

PMID:
17163267

Supplemental Content

Support Center